| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $20.40B | $19.71B | $20.05B |
| YoY Revenue Growth % | +3.5% | -1.7% | — |
| Gross Profit | $3.90B | $3.71B | — |
| Gross Margin % | 19.1% | 18.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.18B | $1.84B | $1.56B |
| Operating Margin % | 5.8% | 9.3% | 7.8% |
| Net Income (GAAP) | $165.0M | $1.79B | $2.94B |
| EBITDA (Normalized) | $1.92B | $2.55B | $2.28B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.19B | $2.45B | $1.90B |
| Capital Expenditures (CapEx) | $917.9M | $887.1M | $902.3M |
| Free Cash Flow (FCF) | $1.27B | $1.56B | $993.7M |
| FCF Margin % | 6.2% | 7.9% | 5.0% |
| Return on Invested Capital (ROIC %) | 6.2% | 9.7% | 8.5% |
| Cash & Short-Term Equivalents | $1.57B | $1.57B | — |
| Total Debt (Short + Long Term) | $7.47B | $7.84B | $5.63B |
| Total Stockholders' Equity | $9.21B | $8.80B | $11.55B |